Stocks to buy post Budget 2025: UPL, Sun Pharma among top 5 stocks to buy that could give 14-37% return - Brokerage Recommendations

[hfe_template id='11223'] [ad_1]
Brokerage Recommendations

1/6

Brokerage Recommendations

Leading brokerages have shared their latest stock recommendations, reflecting varied outlooks across key sectors for the next 12 months.

Motilal Oswal has issued a "Buy" rating on Five-Star Business with a 25% upside potential, while Emkay remains bullish on Sun Pharma, projecting a robust 37% upside.

Investec has upgraded UPL to a "Buy," citing operational improvements, and Jefferies continues to favor ITC with a stable outlook supported by taxation benefits.

Meanwhile, JPMorgan maintains a "Neutral" stance on ONGC, noting near-term growth drivers alongside production concerns.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Agencies

Motilal Oswal on Five-Star Business

2/6

Motilal Oswal on Five-Star Business

Buy | Target Rs 930 | LTP Rs 743 | Upside 25%

Motilal Oswal has given a "Buy" rating on Five-Star Business with a target price of Rs 930, indicating a potential upside of 25% from the last traded price of Rs 743.

ANI

Emkay on Sun Pharma

Buy | Target Rs 2,400 | LTP Rs 1,742 | Upside 37%

Emkay has maintained a "Buy" rating on Sun Pharma with a target price of Rs 2,400, suggesting a potential upside of 37% from the last traded price of Rs 1,742.

Reuters

Investec on UPL

Upgrade to Buy from Sell | Hike target price to Rs 700 from Rs 450 | LTP Rs 604 | Upside 15%

Investec has upgraded UPL from a "Sell" to a "Buy" rating, raising its target price to Rs 700 from the previous Rs 450, implying a potential upside of 15% from the last traded price of Rs 604.

ETMarkets.com

Jefferies on ITC

Maintain Buy | Target Rs 550 | LTP Rs 462 | Upside 19%

Jefferies has maintained its "Buy" rating on ITC with a target price of Rs 550, indicating a potential upside of 19% from the last traded price of Rs 462.

ETMarkets.com

JPMorgan on ONGC

Maintain Neutral | Target Rs 293 | LTP Rs 257 | Upside 14%

JPMorgan has maintained a "Neutral" rating on ONGC with a target price of Rs 293, suggesting a potential upside of 14% from the last traded price of Rs 257.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

ANI

[ad_2] Source link https://mrgaga.in/stocks-to-buy-post-budget-2025-upl-sun-pharma-among-top-5-stocks-to-buy-that-could-give-14-37-return-brokerage-recommendations/?feed_id=46468&_unique_id=67a1a74b9d944

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more